Table 1.
Characteristics at study entry for the whole study population and the subgroup observed until month 36
| Characteristics | All observations | Visited month 36 | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Total | 1,288 | 100.0 | 832 | 100.0 | |
| Female | 751 | 58.3 | 488 | 58.7 | |
| Male | 537 | 41.7 | 344 | 41.3 | |
| Age [years] (mean ± SD) | 36.1 ± 9.3 | 37.1 ± 9.2 | |||
| Age group [years] | |||||
| 18–24 | 117 | 9.1 | 57 | 6.8 | |
| 25–34 | 503 | 39.1 | 302 | 36.3 | |
| 35–44 | 445 | 34.5 | 307 | 36.9 | |
| 45–54 | 170 | 13.2 | 128 | 15.4 | |
| 55–64 | 43 | 3.3 | 33 | 4.0 | |
| 65 + | 10 | 0.8 | 5 | 0.6 | |
| Diabetes mellitus type 2 | 14 | 1.1 | 9 | 1.1 | |
| History of hypertension at study entry | |||||
| Self-reported, treated, uncontrolled | 27 | 2.1 | 17 | 2.0 | |
| Self-reported, treated, controlled | 10 | 0.8 | 5 | 0.6 | |
| Self-reported, untreated, uncontrolled | 15 | 1.2 | 9 | 1.1 | |
| Self-reported, untreated, controlled | 22 | 1.7 | 14 | 1.7 | |
| Systolic blood pressure [mmHg] (mean ± SD) | 118.3 ± 20.4 | 119.9 ± 20.5 | |||
| Diastolic blood pressure [mmHg] (mean ± SD) | 75.7 ± 14.0 | 76.6 ± 14.1 | |||
| Mean arterial pressure [mmHg] (mean ± SD) | 89.9 ± 15.4 | 90.9 ± 15.5 | |||
| Blood pressure categories (ESC/ESH) | |||||
| Optimal | 653 | 50.7 | 396 | 47.6 | |
| Normal | 261 | 20.3 | 173 | 20.8 | |
| High normal | 157 | 12.2 | 101 | 12.1 | |
| Grade 1 hypertension | 154 | 12.0 | 117 | 14.1 | |
| Grade 2 hypertension | 28 | 2.1 | 18 | 2.2 | |
| Grade 3 hypertension | 35 | 2.7 | 27 | 3.2 | |
| Weight (at baseline) [kg] (mean ± SD) | 60.1 ± 11.8 | 60.7 ± 12.0 | |||
| Missing | 4 | 0.3 | 4 | 0.5 | |
| Body mass index [kg/m2] | |||||
| < 18.5 | 67 | 5.2 | 32 | 3.9 | |
| 18.5–24.9 | 767 | 59.6 | 484 | 58.2 | |
| 25.0–29.9 | 298 | 23.1 | 211 | 25.3 | |
| ≥ 30.0 | 152 | 11.8 | 101 | 12.1 | |
| Missing | 4 | 0.3 | 4 | 0.5 | |
| eGFR [mL/min/1.73m2] (median; IQR) | 102; 84 – 116 | 101; 84 – 114 | |||
| Missing | 12 | 0.9 | 6 | 0.7 | |
| WHO HIV stage | |||||
| 1 | 603 | 46.8 | 403 | 48.4 | |
| 2 | 212 | 16.4 | 147 | 17.7 | |
| 3 | 396 | 30.8 | 237 | 28.5 | |
| 4 | 77 | 6.0 | 45 | 5.4 | |
| CD4 count [cells/mm3] (median; IQR) | 281; 128 – 426 | 296; 151 – 426 | |||
| Missing | 182 | 14.1 | 149 | 17.9 | |
| Viral load [copies/mL] (median; IQR) | 33,992; 6,968 –145,868 | 28,832; 6,012 – 129,634 | |||
| Missing | 40 | 3.1 | 26 | 3.1 | |
| Hemoglobin [g/dL] (median; IQR) | 12.5; 11.0 – 13.8 | 12.6; 11.0 – 13.9 | |||
| Missinga | 236 | 18.3 | 139 | 16.7 | |
| Hematocrit [%] (median; IQR) | 37.7; 33.1 – 41.9 | 38.1; 33.4 – 42.3 | |||
| RBC [106/mm3] (median; IQR) | 4.40; 3.96 – 4.88 | 4.42; 4.00 – 4.92 | |||
| WBC [cells/mm3] (median; IQR) | 4,500; 3,600 –5,600 | 4,450; 3,600 – 5,500 | |||
| Platelet count [103/mm3] (median; IQR) | 226; 174 – 295 | 222; 172 – 286 | |||
| Missing | 363 | 28.2 | 224 | 26.9 | |
SD standard deviation, IQR interquartile range, eGFR estimated glomerular filtration rate, RBC erythrocyte count, WBC leucocyte count, aapplies also to hematocrit, RBC, WBC